Ajax-Loading

Company Selected - WuXi Biologics - Income Statement















Ajax-Loading
Fiscal Year is From January To December - All Figures are in , Thousands, Except for the Diluted EPS Figure06/30/202503/31/202512/31/202409/30/2024View Chart

Total Revenue

20,054,37318,675,371.0018,675,37117,116,423.00

[-] Cost of Goods Sold (COGS) incl. D&A

11,500,65211,024,551.0011,024,55110,499,205.00

Hid COGS excluding D&A

11,500,65211,024,551.0011,024,55110,499,205.00

Hid Depreciation & Amortization Expense

0.00.00.00.0

Gross Profit

8,553,7217,650,8207,650,8206,617,218

[-] Operating Expenses

2,675,3382,677,0162,677,0163,151,581

Hid Selling General Administrative (SG&A)

2,202,3142,147,115.002,147,1152,000,373.00

Hid Research & Development

765,893766,443.00766,443795,199.00

Hid Other Operating Expenses

-292,869-236,542-236,542356,009

Operating Income

5,878,3834,973,804.004,973,8043,465,637.00

[-] Net Interest Income

- - - -

Hid Interest Expense

512,746504,360488,172394,370

Hid Interest Income

84,243.00147,024.00147,024137,072.00

Hid Total Other Finance Cost

-428,503-357,336-341,148-257,298

Total Other Income Expense Net

275,739-139,406.00-139,406187,567.00

Income Before Tax

6,154,1224,834,398.004,834,3983,653,204.00

Tax Provision

1,232,450889,027.00889,027640,130.00

[-] Net Income Applicable To Common Shares

4,196,2673,356,081.003,356,0812,632,134.00

Hid [-] Net Income

4,196,2673,356,081.003,356,0812,632,134.00

HidHid [-] Net Income Including Non-Controlling Interests

4,921,6723,945,371.003,945,3713,013,074.00

HidHidHid Net Income From Continuing Ops

- - - -

HidHidHid Discontinued Operations

- - - -

HidHid Minority Interest Expense

725,405589,290.00589,290380,940.00

Hid Preferred Stock And Other Adjustments

0.00.00.00.0

Diluted EPS

10.790.790.61

Diluted Average Shares

4,185,757 - 4,227,165 -

EBITDA

7,405,1056,429,039.006,429,0394,601,109.00

EBIT

5,896,5644,991,985.004,991,9853,450,058.00